Nanoform wins Star of Innovation award at the European Small and Mid-Cap Awards 2021
Press release Nanoform Finland Plc November 17, 2021 10:15 a.m.…
Nanoform receives ISO/IEC 27001:2013 certification for its Information Security Management System
Press release Nanoform Finland Plc November 12, 2021 11:00 a.m.…
Invitation to presentation of Nanoform’s Q3/2021 report on November 25, 2021
Press release Nanoform Finland Plc November 11, 2021 11:00 a.m.…
Nanoform receives funding to solve challenges for global health
Press release Nanoform Finland Plc September 29, 2021 03:45 p.m.…
Nanoform shortlisted for the European Small and Mid-Cap Awards 2021
Press release Nanoform Finland Plc September 23, 2021 14:30 a.m.…
Nanoform technology delivers successful results for Herantis CDNF drug candidate
Press release Nanoform Finland Plc September 9, 2021 08:00 a.m.…
Invitation to presentation of Nanoform’s Q2/2021 report on August 26, 2021
Press release Nanoform Finland Plc August 12, 2021 11:00 a.m.…
Nanoform and Boehringer Ingelheim execute master services agreement
Press release Nanoform Finland Plc August 3, 2021 08:10 a.m.…
Nanoform and Celanese Explore Ways to Enhance Drug Delivery
Press release Nanoform Finland Plc May 25, 2021 04:00 p.m.…
Nanoform’s final clinical results confirm value proposition to the pharma industry
Press release Nanoform Finland Plc May 18, 2021 08:10 a.m.…
Invitation to presentation of Nanoform’s Q1/2021 report on May 27, 2021
Press release Nanoform Finland Plc May 12, 2021 11:00 a.m.…
Nanoform and Aprecia collaborate to advance 3D printed Nanomedicines
Press release Nanoform Finland Plc April 21st, 2021 08:10 a.m.…
Nanoform and Nacuity Pharmaceuticals Sign Technology Proof of Concept (“PoC”) Agreement for Two Ophthalmic Drug Candidates
Press release Nanoform Finland Plc March 31, 2021 08:10 a.m.…
Nanoform launches next-generation STARMAP® v2.0, the AI-based drug candidate selection tool for CESS®
Press release Nanoform Finland Plc March 22, 2021 08:10 a.m.…
Invitation to presentation of Nanoform’s year-end report for 2020 on February 26, 2021
Press release Nanoform Finland Plc February 12, 2021 11:00 a.m.…
Nanoform and Herantis sign Biologics Proof of Concept Agreement
Press release Nanoform Finland Plc February 9th, 2021 08:10 a.m.…
Finnish Foundation for Share Promotion and Nasdaq Helsinki has chosen Nanoform as the company of the month (article in Finnish)
Helsinki, Finland – Finnish Foundation for Share Promotion (Pörssisäätiö/Börsstiftelsen) and…